Zacks Investment Research | Nov 16, 2018 06:28AM ET
Ashland Global Holdings Inc. (NYSE:ASH) said that it has agreed to divest its Composites unit and the butanediol (“BDO”) manufacturing facility in Marl, Germany, to London-based INEOS Enterprises in a deal worth around $1.1 billion. INEOS is among the world’s biggest manufacturers of chemicals and oil products with annual sales of $60 billion.
The Composites business is a global leader in unsaturated polyester resins, vinyl ester resins and gel coats. The Marl BDO facility and related merchant products included in the deal are part of Ashland’s Intermediates and Solvents division. These businesses have combined annual sales of more than $1.1 billion. Ashland stated that it will retain its BDO plant in Lima, OH, to ensure consistent supply for its internal needs.
The transaction, which is subject to regulatory approvals, completion of required employee information, consultation processes and standard closing conditions, is expected to close before the end of the June 2019 quarter. Citi is acting as financial advisor to Ashland while Squire Patton Boggs LLP is acting as legal advisor for the deal.
Ashland anticipates net proceeds of around $1 billion from the divestitures and expects to use that proceeds primarily for debt reduction. Before reporting its first-quarter fiscal 2019 results, the company plans to update its outlook for both the first quarter and fiscal 2019 to reflect the impact of moving these businesses to discontinued operations.
Ashland noted that the sale of these businesses is in sync with its goal of having a more streamlined and focused product portfolio that will reduce earnings volatility and improve margins. The company said that it will be better placed to deliver sustained earnings growth and create significant value for its shareholders.
Ashland’s shares are up around 15.7% so far this year, outperforming its industry ’s 2.3% decline.
The company swung to a profit of $9 million or 15 cents per share in the fourth quarter of fiscal 2018 (ended Sep 30, 2018) from a loss of $58 million or 92 cents a year ago. Adjusted earnings of 97 cents per share fell shy of the Zacks Consensus Estimate of 98 cents. Sales for the quarter went up roughly 9% year over year to $956 million and topped the Zacks Consensus Estimate of $929.2 million.
Sales for the Composites unit rose roughly 8% year over year to $237 million driven by strong performance in North America during the quarter. The company’s Intermediates and Solvents segment raked in sales of $83 million in the quarter, up roughly 32% year over year.
Ashland currently carries a Zacks Rank #2 (Buy).
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.